You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Locating the Elderly Overseen by Nurses- LEON
SBC: Q-Track Corporation Topic: NIADESCRIPTION (provided by applicant): The proposed effort aims to develop a comprehensive wireless tracking and monitoring system for residents of Long Term Care facilities. The commercial product ElderAlertTM extends Q-Track's real-time location system totrack residents, caregivers, and medical assets within a LTC facility. ElderAlertTM directs caregivers to residents who have fallen or have ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
A NOVEL MICROFLUIDIC DEVICE FOR SELECTION AND OPTIMIZATION OF DRUG DELIVERY VEHIC
SBC: CFD RESEARCH CORPORATION Topic: NCIDESCRIPTION (provided by applicant): We propose to develop and demonstrate a novel microfluidic device and assay for selection and optimization of delivery vehicles, specifically non-viral vectors for drug delivery to tumors. Tumor drug delivery is a complex phenomenon affected by several elements in addition to drug or delivery vehicle's physico-chemical properties. A key factor is tumor mic ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Targeted Treatment of Recurrent Small Cell Lung Cancer with Anti-AbnV2 Antibodies
SBC: Woomera Therapeutics, Inc. Topic: NCIDESCRIPTION (provided by applicant): There is currently no effective treatment for recurrent small-cell lung cancer (rSCLC). The objective of this project is to utilize a monoclonal antibody, Abner, to develop new, rational, and successful treatment of rSCLC. The hypothesis being tested is that an abnormal vasopressin type 2 receptor (AbnV2R) present on these tumors will provide a sensitive, tumor ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
New In Vitro Human Liver Toxicity Bioassay System
SBC: Vivo Biosciences Inc Topic: NIEHSDESCRIPTION (provided by applicant): The overall objective of this SBIR proposal is to develop and commercialize a human 3D or mini- liver bioassay system suitable for real-time analysis of metabolic functions and long-term drug toxicity profiles. At present, liver functions are mostly studied using HepG2 cell line and primary hepatocytes cultured onto collagen or polymer matrices. However, these ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
A novel physiologically realistic microfluidic in-vitro blood-brain barrier model
SBC: CFD RESEARCH CORPORATION Topic: NIGMSDESCRIPTION (provided by applicant): The overall objective of this study is to develop a novel in vitro microfluidic platform to test a drug or delivery vehicle's ability to permeate the Blood-Brain Barrier (BBB). In contrast to current in-vitro models, our proposed device, SIM-BBB, comprises of a microfluidic two-compartment chamber. The chamber is designed in such a way as to permit vis ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Dynamic Perturbation Training System for ACL Rehabilitation
SBC: Simbex LLC Topic: NICHDDESCRIPTION (provided by applicant): Anterior cruciate ligament (ACL) injuries are a significant problem for athletes, and women in particular. Both surgical and non-surgical treatment options exist, with the ultimate goal of regaining joint stability, knee kinematics, and quadriceps strength compared to the uninjured contralateral limb to allow full return of function and activity level and to p ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Depletion of Dendritic Cells by Immunotoxin as Therapy for Myocardial Infarction
SBC: CELDARA MEDICAL, LLC Topic: NHLBIDESCRIPTION (provided by applicant): MI is the leading cause of death in the developed world, including the United States. In 2005 over 8.1 million Americans had an MI; 30% died before reaching hospital and 10% died after hospitalization. It is the 70% whoreach hospital that we believe we can help - a million lives in the balance and an improved quality of life for millions more - in the US alone. ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
ChNKG2D-Targeted Cellular Cancer Therapy: Phase I Clinical Trial
SBC: CELDARA MEDICAL, LLC Topic: NHLBIDESCRIPTION (provided by applicant): The global burden of cancer doubled between 1975 and 2000. Cancer became the leading cause of death worldwide in 2010, and is projected to double again by 2020 and to triple by 2030. This horrible disease has touched each of us, and despite enormous investments in prevention and treatment, its impact continues to accelerate. Ideally, any cancer therapy should ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Design and development of a multifunctional self-service health screening kiosk
SBC: Pursuant HEALTH, INC. Topic: NIMHDDESCRIPTION (provided by applicant): This Fast-Track SBIR proposal submitted by SoloHealth of Duluth, Georgia, requests grant funds to build and test a multifunction health-screening kiosk. Our current kiosk prototype, EyeSite, has demonstrated efficacy inreaching low income, high health disparity populations with over 109,000 uses in less than 9 months of testing. Our goal is to expand the offeri ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health -
Toda Promotora Clearinghouse: Supporting nonprofits' use of promotores
SBC: KDH Research & Communication, Inc. Topic: NIMHDDESCRIPTION (provided by applicant): The objective of this Fast Track Small Business Innovation Research application, submitted by KDH Research and Communication (KDHRC), is to develop and evaluate an online information clearinghouse to support community-based nonprofit organizations' (NPOs) use of promotores programs to provide health information to underserved Latinos. Promotores programs u ...
SBIR Phase II 2012 Department of Health and Human ServicesNational Institutes of Health